Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

7JPH

Crystal structure of EBOV glycoprotein with modified HR1c and HR2 stalk at 3.2 A resolution

7JPH の概要
エントリーDOI10.2210/pdb7jph/pdb
分子名称Envelope glycoprotein, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, alpha-D-mannopyranose-(1-3)-alpha-D-mannopyranose-(1-6)-[alpha-D-mannopyranose-(1-3)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, ... (6 entities in total)
機能のキーワードebola glycoprotein, viral protein
由来する生物種Ebola virus - Mayinga, Zaire, 1976 (ZEBOV)
詳細
タンパク質・核酸の鎖数2
化学式量合計53094.31
構造登録者
Chaudhary, A.,Stanfield, R.L.,Wilson, I.A.,Zhu, J. (登録日: 2020-08-08, 公開日: 2021-04-07, 最終更新日: 2024-11-20)
主引用文献He, L.,Chaudhary, A.,Lin, X.,Sou, C.,Alkutkar, T.,Kumar, S.,Ngo, T.,Kosviner, E.,Ozorowski, G.,Stanfield, R.L.,Ward, A.B.,Wilson, I.A.,Zhu, J.
Single-component multilayered self-assembling nanoparticles presenting rationally designed glycoprotein trimers as Ebola virus vaccines.
Nat Commun, 12:2633-2633, 2021
Cited by
PubMed Abstract: Ebola virus (EBOV) glycoprotein (GP) can be recognized by neutralizing antibodies (NAbs) and is the main target for vaccine design. Here, we first investigate the contribution of the stalk and heptad repeat 1-C (HR1) regions to GP metastability. Specific stalk and HR1 modifications in a mucin-deleted form (GPΔmuc) increase trimer yield, whereas alterations of HR1 exert a more complex effect on thermostability. Crystal structures are determined to validate two rationally designed GPΔmuc trimers in their unliganded state. We then display a modified GPΔmuc trimer on reengineered protein nanoparticles that encapsulate a layer of locking domains (LD) and a cluster of helper T-cell epitopes. In mice and rabbits, GP trimers and nanoparticles elicit cross-ebolavirus NAbs, as well as non-NAbs that enhance pseudovirus infection. Repertoire sequencing reveals quantitative profiles of vaccine-induced B-cell responses. This study demonstrates a promising vaccine strategy for filoviruses, such as EBOV, based on GP stabilization and nanoparticle display.
PubMed: 33976149
DOI: 10.1038/s41467-021-22867-w
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (3.195 Å)
構造検証レポート
Validation report summary of 7jph
検証レポート(詳細版)ダウンロードをダウンロード

248335

件を2026-01-28に公開中

PDB statisticsPDBj update infoContact PDBjnumon